Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm

NCT01905228 is registered in ClinicalTrials.gov with Incuron as lead sponsor.

NCT NCT01905228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01905228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Trial of CBL0137 in Patients With Metastatic or Unresectable Advanced Solid Neoplasm
Lead sponsor
Incuron
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2013
Completion date
June 30, 2019
Enrollment
83 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma, solid tumors